Denali Therapeutics Inc.
(DNLI - NASDAQ)
19,89 USD
📋 Profilo Aziendale

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States.

|